Equillium (EQ) Common Equity (2017 - 2026)
Equillium (EQ) reported Common Equity of $59.5 million for Q1 2026, up 462.37% year-over-year from $10.6 million in Q1 2025, and up 108.02% quarter-over-quarter from $28.6 million in Q4 2025.
Equillium (EQ) Common Equity (2017 - 2026) Analysis & Trends
Equillium (EQ) has 10 years of Common Equity data on file, last reported at $59.5 million in Q1 2026.
- Common Equity for Q1 2026 came in at $59.5 million, up 462.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $59.5 million (up 462.37% YoY), and the FY2025 annual result was $28.6 million, up 50.03% from the prior year.
- Common Equity rose to $59.5 million in Q1 2026 per EQ's latest filing, from $28.6 million in the prior quarter.
- Over five years, Common Equity peaked at $59.5 million in Q1 2026 and troughed at $5.1 million in Q2 2025.
- A 5-year average of $28.0 million and a median of $27.0 million in 2023 frame the typical range for Common Equity.
- The sharpest annual moves came in 2025 and 2026: Common Equity tumbled 77.46% in 2025, then surged 462.37% in 2026.
- A 5-year view of Common Equity shows it stood at $31.9 million in 2022, then retreated by 29.33% to $22.6 million in 2023, then slipped by 15.56% to $19.1 million in 2024, then soared by 50.03% to $28.6 million in 2025, then soared by 108.02% to $59.5 million in 2026.
- Business Quant data shows EQ's Common Equity at $59.5 million in Q1 2026, $28.6 million in Q4 2025, and $30.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 35.63 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.42 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 13.21 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 11.87 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | 59.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.49 Mn |
| Dec 31, 2025 | 28.60 Mn |
| Sep 30, 2025 | 30.94 Mn |
| Jun 30, 2025 | 5.06 Mn |
| Mar 31, 2025 | 10.58 Mn |
| Dec 31, 2024 | 19.06 Mn |
| Sep 30, 2024 | 23.18 Mn |
| Jun 30, 2024 | 22.43 Mn |
| Mar 31, 2024 | 21.09 Mn |
| Dec 31, 2023 | 22.57 Mn |
| Sep 30, 2023 | 24.11 Mn |
| Jun 30, 2023 | 26.98 Mn |
| Mar 31, 2023 | 29.27 Mn |
| Dec 31, 2022 | 31.94 Mn |
| Sep 30, 2022 | 28.16 Mn |
| Jun 30, 2022 | 40.27 Mn |
| Mar 31, 2022 | 52.63 Mn |
| Dec 31, 2021 | 66.51 Mn |
| Sep 30, 2021 | 75.80 Mn |
| Jun 30, 2021 | 84.77 Mn |